Search Results - "Wolff, Antonio C"

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update by Allison, Kimberly H, Hammond, M Elizabeth H, Dowsett, Mitchell, McKernin, Shannon E, Carey, Lisa A, Fitzgibbons, Patrick L, Hayes, Daniel F, Lakhani, Sunil R, Chavez-MacGregor, Mariana, Perlmutter, Jane, Perou, Charles M, Regan, Meredith M, Rimm, David L, Symmans, W Fraser, Torlakovic, Emina E, Varella, Leticia, Viale, Giuseppe, Weisberg, Tracey F, McShane, Lisa M, Wolff, Antonio C

“…To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR)…”
Get full text

CDK4 and CDK6 Inhibition in Breast Cancer — A New Standard by Wolff, Antonio C

“…Breast cancer is the most prevalent type of malignant neoplasm worldwide, and estrogen-receptor (ER)–positive breast cancer is the most common phenotype…”
Get full text

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update by Wolff, Antonio C, Hammond, M Elizabeth Hale, Allison, Kimberly H, Harvey, Brittany E, Mangu, Pamela B, Bartlett, John M S, Bilous, Michael, Ellis, Ian O, Fitzgibbons, Patrick, Hanna, Wedad, Jenkins, Robert B, Press, Michael F, Spears, Patricia A, Vance, Gail H, Viale, Giuseppe, McShane, Lisa M, Dowsett, Mitchell

“…Purpose To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2…”
Get full text

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update by Wolff, Antonio C, Hammond, M Elizabeth Hale, Allison, Kimberly H, Harvey, Brittany E, Mangu, Pamela B, Bartlett, John M S, Bilous, Michael, Ellis, Ian O, Fitzgibbons, Patrick, Hanna, Wedad, Jenkins, Robert B, Press, Michael F, Spears, Patricia A, Vance, Gail H, Viale, Giuseppe, McShane, Lisa M, Dowsett, Mitchell

“…To update key recommendations of the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) human epidermal growth factor receptor…”
Get full text

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199 by Adams, Sylvia, Gray, Robert J, Demaria, Sandra, Goldstein, Lori, Perez, Edith A, Shulman, Lawrence N, Martino, Silvana, Wang, Molin, Jones, Vicky E, Saphner, Thomas J, Wolff, Antonio C, Wood, William C, Davidson, Nancy E, Sledge, George W, Sparano, Joseph A, Badve, Sunil S

“…Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated with disease-free (DFS) and overall survival (OS) in operable triple-negative…”
Get full text

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes by Tung, Nadine M, Robson, Mark E, Ventz, Steffen, Santa-Maria, Cesar A, Nanda, Rita, Marcom, Paul K, Shah, Payal D, Ballinger, Tarah J, Yang, Eddy S, Vinayak, Shaveta, Melisko, Michelle, Brufsky, Adam, DeMeo, Michelle, Jenkins, Colby, Domchek, Susan, D'Andrea, Alan, Lin, Nancy U, Hughes, Melissa E, Carey, Lisa A, Wagle, Nick, Wulf, Gerburg M, Krop, Ian E, Wolff, Antonio C, Winer, Eric P, Garber, Judy E

“…Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor (PARPi), is approved for the treatment of human epidermal growth factor receptor 2 (HER2)-negative…”
Get full text

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update by WOLFF, Antonio C, HAMMOND, M. Elizabeth H, HANNA, Wedad, JENKINS, Robert B, MANGU, Pamela B, SOONMYUNG PAIK, PEREZ, Edith A, PRESS, Michael F, SPEARS, Patricia A, VANCE, Gail H, VIALE, Giuseppe, HAYES, Daniel F, HICKS, David G, DOWSETT, Mitch, MCSHANE, Lisa M, ALLISON, Kimberly H, ALLRED, Donald C, BARTLETT, John M. S, BILOUS, Michael, FITZGIBBONS, Patrick

“…To update the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for human epidermal growth factor…”
Get full text

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update by Allison, Kimberly H, Hammond, M Elizabeth H, Dowsett, Mitchell, McKernin, Shannon E, Carey, Lisa A, Fitzgibbons, Patrick L, Hayes, Daniel F, Lakhani, Sunil R, Chavez-MacGregor, Mariana, Perlmutter, Jane, Perou, Charles M, Regan, Meredith M, Rimm, David L, Symmans, W Fraser, Torlakovic, Emina E, Varella, Leticia, Viale, Giuseppe, Weisberg, Tracey F, McShane, Lisa M, Wolff, Antonio C

“…To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen receptor (ER) and progesterone receptor…”
Get full text

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial by Piccart-Gebhart, Martine, Holmes, Eileen, Baselga, José, de Azambuja, Evandro, Dueck, Amylou C, Viale, Giuseppe, Zujewski, Jo Anne, Goldhirsch, Aron, Armour, Alison, Pritchard, Kathleen I, McCullough, Ann E, Dolci, Stella, McFadden, Eleanor, Holmes, Andrew P, Tonghua, Liu, Eidtmann, Holger, Dinh, Phuong, Di Cosimo, Serena, Harbeck, Nadia, Tjulandin, Sergei, Im, Young-Hyuck, Huang, Chiun-Sheng, Diéras, Véronique, Hillman, David W, Wolff, Antonio C, Jackisch, Christian, Lang, Istvan, Untch, Michael, Smith, Ian, Boyle, Frances, Xu, Binghe, Gomez, Henry, Suter, Thomas, Gelber, Richard D, Perez, Edith A

“…Lapatinib (L) plus trastuzumab (T) improves outcomes for metastatic human epidermal growth factor 2-positive breast cancer and increases the pathologic…”
Get full text

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update by Denduluri, Neelima, Chavez-MacGregor, Mariana, Telli, Melinda L, Eisen, Andrea, Graff, Stephanie L, Hassett, Michael J, Holloway, Jamie N, Hurria, Arti, King, Tari A, Lyman, Gary H, Partridge, Ann H, Somerfield, Mark R, Trudeau, Maureen E, Wolff, Antonio C, Giordano, Sharon H

“…Purpose To update key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy…”
Get full text

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update by KHATCHERESSIAN, James L, HURLEY, Patricia, VOGEL, Victor G, WOLFF, Antonio C, SOMERFIELD, Mark R, DAVIDSON, Nancy E, BANTUG, Elissa, ESSERMAN, Laura J, GRUNFELD, Eva, HALBERG, Francine, HANTEL, Alexander, LYNN HENRY, N, MUSS, Hyman B, SMITH, Thomas J

“…To provide recommendations on the follow-up and management of patients with breast cancer who have completed primary therapy with curative intent. To update…”
Get full text

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer by Sparano, Joseph A, Zhao, Fengmin, Martino, Silvana, Ligibel, Jennifer A, Perez, Edith A, Saphner, Tom, Wolff, Antonio C, Sledge, Jr, George W, Wood, William C, Davidson, Nancy E

“…To determine long-term outcomes in a clinical trial evaluating the role of taxane type and schedule in operable breast cancer and evaluate the impact of…”
Get full text

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update by Wolff, Antonio C, Hammond, M Elizabeth H, Hicks, David G, Dowsett, Mitch, McShane, Lisa M, Allison, Kimberly H, Allred, Donald C, Bartlett, John M S, Bilous, Michael, Fitzgibbons, Patrick, Hanna, Wedad, Jenkins, Robert B, Mangu, Pamela B, Paik, Soonmyung, Perez, Edith A, Press, Michael F, Spears, Patricia A, Vance, Gail H, Viale, Giuseppe, Hayes, Daniel F

“…To update the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for human epidermal growth factor…”
Get full text

Older Adults' Views and Communication Preferences About Cancer Screening Cessation by Schoenborn, Nancy L, Lee, Kimberley, Pollack, Craig E, Armacost, Karen, Dy, Sydney M, Bridges, John F P, Xue, Qian-Li, Wolff, Antonio C, Boyd, Cynthia

“…Older adults with limited life expectancy are frequently screened for cancer even though it exposes them to risks of screening with minimal benefit. Patient…”
Get more information

Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis by PEAIRS, Kimberly S, BARONE, Bethany B, SNYDER, Claire F, YEH, Hsin-Chieh, STEIN, Kelly B, DERR, Rachel L, BRANCATI, Frederick L, WOLFF, Antonio C

“…The goal of this study was to perform a systematic review and meta-analysis to examine the effect of pre-existing diabetes on breast cancer-related outcomes…”
Get full text

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer by CAREY, Lisa A, RUGO, Hope S, WOLFF, Antonio C, HOBDAY, Timothy J, IVANOVA, Anastasia, CHIU, Wing-Keung, FERRARO, Madlyn, BURROWS, Emily, BERNARD, Philip S, HOADLEY, Katherine A, PEROU, Charles M, WINER, Eric P, MARCOM, P. Kelly, MAYER, Erica L, ESTEVA, Francisco J, MA, Cynthia X, LIU, Minetta C, STORNIOLO, Anna Maria, RIMAWI, Mothaffar F, FORERO-TORRES, Andres

“…Epidermal growth factor receptor (EGFR) is a targetable receptor frequently overexpressed in basal-like breast cancer, which comprises most triple-negative…”
Get full text

Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline by Denduluri, Neelima, Somerfield, Mark R, Eisen, Andrea, Holloway, Jamie N, Hurria, Arti, King, Tari A, Lyman, Gary H, Partridge, Ann H, Telli, Melinda L, Trudeau, Maureen E, Wolff, Antonio C

“…A Cancer Care Ontario (CCO) guideline on the selection of optimal adjuvant chemotherapy regimens for early breast cancer including adjuvant targeted therapy…”
Get full text

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer by HAMMOND, M. Elizabeth H, HAYES, Daniel F, HICKS, David G, LESTER, Susan, LOVE, Richard, MANGU, Pamela B, MCSHANE, Lisa, MILLER, Keith, OSBORNE, C. Kent, PAIK, Soonmyung, PERLMUTTER, Jane, RHODES, Anthony, DOWSETT, Mitch, SASANO, Hironobu, SCHWARTZ, Jared N, SWEEP, Fred C. G, TAUBE, Sheila, TORLAKOVIC, Emina Emilia, VALENSTEIN, Paul, VIALE, Giuseppe, VISSCHER, Daniel, WHEELER, Thomas, WILLIAMS, R. Bruce, ALLRED, D. Craig, WITTLIFF, James L, WOLFF, Antonio C, HAGERTY, Karen L, BADVE, Sunil, FITZGIBBONS, Patrick L, FRANCIS, Glenn, GOLDSTEIN, Neil S, HAYES, Malcolm

“…To develop a guideline to improve the accuracy of immunohistochemical (IHC) estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer and…”
Get full text

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer by WOLFF, Antonio C, LAZAR, Ann A, CHAN, Arlene, HACHEMI, Soulef, STRAHS, Andrew, CINCOTTA, Maria, BERKENBLIT, Anna, KRYGOWSKI, Mizue, KANG, Lih Lisa, MOORE, Laurence, HAYES, Daniel F, BONDARENKO, Igor, GARIN, August M, BRINCAT, Stephen, CHOW, Louis, YAN SUN, NESKOVIC-KONSTANTINOVIC, Zora, GUIMARAES, Rodrigo C, FUMOLEAU, Pierre

“…Recent data showed improvement in progression-free survival (PFS) when adding everolimus to exemestane in patients with advanced breast cancer experiencing…”
Get full text

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer by Sparano, Joseph A, Wang, Molin, Martino, Silvana, Jones, Vicky, Perez, Edith A, Saphner, Tom, Wolff, Antonio C, Sledge, George W, Wood, William C, Davidson, Nancy E

“…This randomized trial of adjuvant chemotherapy in women with axillary lymph node–positive or high-risk, lymph node–negative breast cancer showed that weekly…”
Get full text